Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer
NCT02739529
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Gynecologic Cancer
Interventions
DRUG:
Genexol-PM
Sponsor
Samyang Biopharmaceuticals Corporation